Pancreatic cancer is one of the most aggressive and deadly forms of cancer. The five-year survival rate is just 13%. On average, patients survive for only nine months after diagnosis and roughly 66,000 people are diagnosed in the U.S. each year. Now, researchers from Henry Ford Health and MSU are coming together to share their knowledge and expertise with the aim of changing this somber prognosis.

“I completely believe in team science,” said Jennifer Klomp, a pancreatic cancer researcher at Michigan State University. “I think the resulting science is better and more rigorous. You come at something with different approaches, different ways of thinking and different ideas. And the output, in the end, is more beneficial.”